Pacific Medical Systems Limited is pleased to announce its successful participation in the Asia Pacific Intensive Care Symposium (APICS) 2025, held recently in Singapore. The conference attracted over 1,000 intensive care specialists and clinicians from more than 30 countries and regions across the Asia-Pacific.

During the symposium, the company featured the innovative TrueVue Hemodynamic Monitoring System in collaboration with Deltex Medical. The TrueVue System utilizes Oesophageal Doppler Monitoring (ODM) technology to provide clinicians with precise, real-time hemodynamic data for optimized patient management.

The system demonstrates significant clinical value in two key areas:

• Reducing postoperative complications in surgical patients

• Guiding precise fluid and drug therapy for ventilated patients in ICU
  The system is suitable for both adult and pediatric patients weighing as low as 3 kilograms.

Jules Flach, CEO of Pacific Medical Systems Limited, commented, "We were honored to showcase the TrueVue monitoring solution at this prestigious gathering. The strong interest from medical professionals confirms the technology's significant potential in enhancing critical care standards across the region. This aligns perfectly with our commitment to bringing innovative medical solutions to the Asia-Pacific healthcare community."

The exhibition provided an excellent platform for Pacific Medical Systems Limited to strengthen engagement with intensive care specialists and demonstrate the company's dedication to advancing critical care medicine through innovative technologies.